Literature DB >> 20409252

The effect of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept) on wound healing in pigs in vivo and its in vitro percutaneous permeation through intact and barrier disrupted porcine skin.

Jessica Stahl1, Michael Braun, Joerg Siebert, Manfred Kietzmann.   

Abstract

A combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept) is a commonly used disinfectant in human medicine. As porcine skin represents an adequate model for human skin, the effect of octenidine dihydrochloride and phenoxyethanol on wound healing is studied in pigs. Furthermore, the in vitro percutaneous permeation of the test substances is studied. The impact of the test formulations on wound healing is examined (A) under non occlusive conditions and (B) in comparison to another disinfectant based on povidone-iodine under occlusive conditions, while wounds are treated daily with the test substances. The percutaneous permeation of octenidine dihydrochloride and phenoxyethanol is studied in Franz-type diffusion cells with intact skin as well as barrier disrupted after tape stripping. Compared with povidone-iodine or vehicle treatment as well as untreated control wounds the treatment of wounds with the test formulation has no influence on the healing rate in pigs and does not induce retardation of wound healing. The in vitro diffusion experiment reveals that octenidine dihydrochloride is only detectable in the acceptor chamber of three-barrier disrupted skin samples. Phenoxyethanol permeates through intact porcine skin in amounts of 11.3% and through barrier disrupted skin in amounts of 43.9%

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409252      PMCID: PMC7951212          DOI: 10.1111/j.1742-481X.2009.00648.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  34 in total

1.  Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients.

Authors:  Andreas Tietz; Reno Frei; Marc Dangel; Dora Bolliger; Jakob R Passweg; Alois Gratwohl; Andreas E Widmer
Journal:  Infect Control Hosp Epidemiol       Date:  2005-08       Impact factor: 3.254

2.  Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance.

Authors:  Z Al-Doori; P Goroncy-Bermes; C G Gemmell; D Morrison
Journal:  J Antimicrob Chemother       Date:  2007-04-17       Impact factor: 5.790

3.  Treatment of pseudomonas nail infections with 0.1% octenidine dihydrochloride solution.

Authors:  D Rigopoulos; E Rallis; S Gregoriou; G Larios; Y Belyayeva; K Gkouvi; A Katsambas
Journal:  Dermatology       Date:  2008-11-06       Impact factor: 5.366

4.  Percutaneous penetration of 2-phenoxyethanol through rat and human skin.

Authors:  C S Roper; D Howes; P G Blain; F M Williams
Journal:  Food Chem Toxicol       Date:  1997 Oct-Nov       Impact factor: 6.023

5.  Antimycotic effects of octenidine and pirtenidine.

Authors:  M A Ghannoum; K A Elteen; M Ellabib; P A Whittaker
Journal:  J Antimicrob Chemother       Date:  1990-02       Impact factor: 5.790

6.  Effect of the antibacterial agents octenidine and chlorhexidine on the plaque flora in primates.

Authors:  C G Emilson; W H Bowen; S A Robrish; C W Kemp
Journal:  Scand J Dent Res       Date:  1981-10

7.  Effects of octenidine on dental plaque and gingivitis in monkeys.

Authors:  R J Shern; W A Little; J B Kennedy; D B Mirth
Journal:  J Periodontol       Date:  1987-09       Impact factor: 6.993

8.  Microbicidal activity of octenidine hydrochloride, a new alkanediylbis[pyridine] germicidal agent.

Authors:  D M Sedlock; D M Bailey
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

9.  Short-term relative antibacterial effect of octenidine dihydrochloride on the oral microflora in orthodontically treated patients.

Authors:  Alev Aksoy Dogan; Ali K Adiloglu; Suleyman Onal; Emel Sesli Cetin; Esra Polat; Ersin Uskun; Fatih Koksal
Journal:  Int J Infect Dis       Date:  2008-06-06       Impact factor: 3.623

10.  Occlusive versus semi-open dressings in the management of skin graft donor sites.

Authors:  D Demetriades; G Psaras
Journal:  S Afr J Surg       Date:  1992-06       Impact factor: 0.375

View more
  4 in total

1.  Effectiveness and tissue compatibility of a 12-week treatment of chronic venous leg ulcers with an octenidine based antiseptic--a randomized, double-blind controlled study.

Authors:  Wolfgang Vanscheidt; Keith Harding; Luc Téot; Jörg Siebert
Journal:  Int Wound J       Date:  2011-11-10       Impact factor: 3.315

2.  Prospective, double-blinded, randomised controlled trial assessing the effect of an Octenidine-based hydrogel on bacterial colonisation and epithelialization of skin graft wounds in burn patients.

Authors:  Eisenbeiß W; Siemers F; Amtsberg G; Hinz P; Hartmann B; Kohlmann T; Ekkernkamp A; Albrecht U; Assadian O; Kramer A
Journal:  Int J Burns Trauma       Date:  2012-09-15

3.  The percutaneous permeation of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept®) through skin of different species in vitro.

Authors:  Jessica Stahl; Michael Braun; Joerg Siebert; Manfred Kietzmann
Journal:  BMC Vet Res       Date:  2011-08-11       Impact factor: 2.741

4. 

Authors:  J Köhnlein; F V Rheinbaben; S Werner
Journal:  Krankenhaushyg Infektionsverhut       Date:  2016-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.